ASX - By Stock
|
CMB |
Re:
Ann: Director Appointment Dr. Tseng
|
|
Prorata
|
3 |
1.3K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Letter to Shareholders - GM
|
|
Prorata
|
4 |
1.7K |
3 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Chairman's Address and CEO update
|
|
Prorata
|
12 |
5.1K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
12
|
5.1K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Chairman's Address and CEO update
|
|
Prorata
|
12 |
5.1K |
1 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
12
|
5.1K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Prorata
|
2 |
1.4K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
2
|
1.4K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Post-merger
|
|
Prorata
|
1 |
1.0K |
2 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
1
|
1.0K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Notice of Termination of Kyocera Licence
|
|
Prorata
|
34 |
16K |
4 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
34
|
16K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
What am I missing here?
|
|
Prorata
|
9 |
4.5K |
0 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
9
|
4.5K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
What am I missing here?
|
|
Prorata
|
9 |
4.5K |
2 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
9
|
4.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
Prorata
|
267 |
64K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
267
|
64K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for that 55% surge?
|
|
Prorata
|
44 |
11K |
1 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
44
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022 - Momma says life is like a box of chocolates
|
|
Prorata
|
222 |
57K |
2 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
222
|
57K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Prorata
|
13K |
5.0M |
8 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Over $2buck hit
|
|
Prorata
|
15 |
6.2K |
0 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
15
|
6.2K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Coming News ???
|
|
Prorata
|
510 |
222K |
6 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
510
|
222K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Something big is coming - White House briefing
|
|
Prorata
|
97 |
42K |
1 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
97
|
42K
|
1
|
|
Charts
|
CSL |
Re:
The CSL pattern
|
|
Prorata
|
1.3K |
672K |
1 |
22/07/20 |
22/07/20 |
Charts
|
1.3K
|
672K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Prorata
|
23K |
13M |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
Prorata
|
31 |
9.9K |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
31
|
9.9K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
Prorata
|
31 |
9.9K |
1 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
31
|
9.9K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
Prorata
|
31 |
9.9K |
1 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
31
|
9.9K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Regeneus signs MOU with Kyocera Corporation
|
|
Prorata
|
19 |
196K |
1 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
19
|
196K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Japanese like stem cell technologies
|
|
Prorata
|
5 |
4.3K |
2 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
5
|
4.3K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
CSL has more upside...
|
|
Prorata
|
425 |
2.4M |
5 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
425
|
2.4M
|
5
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Analyst Presentation
|
|
Prorata
|
190 |
95K |
0 |
25/04/18 |
25/04/18 |
ASX - By Stock
|
190
|
95K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
|
|
Prorata
|
116 |
45K |
4 |
25/04/18 |
25/04/18 |
ASX - By Stock
|
116
|
45K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Diabetes.......where are we at?
|
|
Prorata
|
7 |
3.7K |
3 |
03/07/17 |
03/07/17 |
ASX - By Stock
|
7
|
3.7K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
New RGS Presentation
|
|
Prorata
|
13 |
5.4K |
0 |
28/06/17 |
28/06/17 |
ASX - By Stock
|
13
|
5.4K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
New RGS Presentation
|
|
Prorata
|
13 |
5.4K |
2 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
13
|
5.4K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL to Acquire Majority Stake in Chinese Plasma Fractionator
|
|
Prorata
|
40 |
26K |
0 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
40
|
26K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Why the big drop?
|
|
Prorata
|
84 |
33K |
2 |
19/06/17 |
19/06/17 |
ASX - By Stock
|
84
|
33K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast says qtrly loss attributable $9.8 mln
|
|
Prorata
|
85 |
39K |
8 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
85
|
39K
|
8
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Japanese Patent Office to grant key patent for Progenza
|
|
Prorata
|
21 |
11K |
3 |
29/05/17 |
29/05/17 |
ASX - By Stock
|
21
|
11K
|
3
|
|
ASX - By Stock
|
TGS |
Re:
Ann: March 2017 Quarterly Activities Report
|
|
Prorata
|
107 |
50K |
0 |
26/05/17 |
26/05/17 |
ASX - By Stock
|
107
|
50K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
things I've learnt over the last 14 months
|
|
Prorata
|
25 |
11K |
3 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
25
|
11K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
All time high
|
|
Prorata
|
72 |
34K |
1 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
72
|
34K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB's Potential Partner
|
|
Prorata
|
23 |
11K |
3 |
19/05/17 |
19/05/17 |
ASX - By Stock
|
23
|
11K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 4C - Quarterly
|
|
Prorata
|
11 |
5.5K |
1 |
19/05/17 |
19/05/17 |
ASX - By Stock
|
11
|
5.5K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Goodbye to $100?
|
|
Prorata
|
154 |
64K |
1 |
05/04/17 |
05/04/17 |
ASX - By Stock
|
154
|
64K
|
1
|
|
ASX - By Stock
|
SYR |
Re:
Syrah with BHP Billiton Management
|
|
Prorata
|
48 |
24K |
1 |
23/03/17 |
23/03/17 |
ASX - By Stock
|
48
|
24K
|
1
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
Prorata
|
1.1K |
665K |
0 |
23/03/17 |
23/03/17 |
Charts
|
1.1K
|
665K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Mesoblast Fast Track Designation For GVHD
|
|
Prorata
|
22 |
13K |
4 |
07/03/17 |
07/03/17 |
ASX - By Stock
|
22
|
13K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Fear
|
|
Prorata
|
8 |
4.5K |
8 |
06/03/17 |
06/03/17 |
ASX - By Stock
|
8
|
4.5K
|
8
|
|
World Politics
|
|
Re:
The Almighty President of the USA
|
|
Prorata
|
27 |
5.2K |
4 |
02/03/17 |
02/03/17 |
World Politics
|
27
|
5.2K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Heart Failure
|
|
Prorata
|
60 |
23K |
2 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
60
|
23K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
BP Update - RA
|
|
Prorata
|
33 |
14K |
0 |
21/02/17 |
21/02/17 |
ASX - By Stock
|
33
|
14K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
BP Update - RA
|
|
Prorata
|
33 |
14K |
1 |
20/02/17 |
20/02/17 |
ASX - By Stock
|
33
|
14K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Analysts Presentation
|
|
Prorata
|
41 |
14K |
2 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
41
|
14K
|
2
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Executive Chairman Remuneration Update
|
|
Prorata
|
9 |
4.4K |
1 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
9
|
4.4K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Positive Nine Month RA Results For Mesoblast Cell Therapy
|
|
Prorata
|
44 |
14K |
2 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
44
|
14K
|
2
|
|